References
- Arikan SK, Kasap B, Yetimalar H, et al (2014). Impact of prognostic factors on survival rates in patients with ovarian carcinoma. Asian Pac J Cancer Prev, 15, 6087-94. https://doi.org/10.7314/APJCP.2014.15.15.6087
- Byun DS, Cho K, Ryu BK, et al (2003). Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res, 63, 7068-75.
- Chen XY, He QY, Guo MZ (2012). XAF1 is frequently methylated in human esophageal cancer. World J Gastroenterol, 18, 2844-9. https://doi.org/10.3748/wjg.v18.i22.2844
- Chen YB, Shu J, Yang WT, et al (2011). XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer. Chin Med J, 124, 3238-43.
- Kempkensteffen C, Fritzsche FR, Johannsen M, et al (2009). Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer, 9, 276. https://doi.org/10.1186/1471-2407-9-276
- Kempkensteffen C, Hinz S, Schrader M, et al (2007). Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome. Cancer Lett, 254, 227-35. https://doi.org/10.1016/j.canlet.2007.03.006
- Kim MA, Lee HE, Lee HS, et al (2011). Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma. Virchows Arch, 459, 503-10. https://doi.org/10.1007/s00428-011-1150-6
- LeBleu VS, Taduri G, O'Connell J, et al (2013). Origin and function of myofibroblasts in kidney fibrosis. Nat Med, 19, 1047-53. https://doi.org/10.1038/nm.3218
- Li G, Chang H, Zhai YP, et al (2013). Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 4943-52.
- Li XQ, Ke XZ, Wang YM (2012). Treatment of malignant melanoma by downregulation of XIAP and overexpression of TRAIL with a conditionally replicating oncolytic adenovirus. Asian Pac J Cancer Prev, 13, 1471-6. https://doi.org/10.7314/APJCP.2012.13.4.1471
- Ling ZQ, Lv P, Lu XX, et al (2013). Circulating methylated DNA Indicates poor prognosis for gastric cancer. PLoS One, 8, 67195. https://doi.org/10.1371/journal.pone.0067195
- Liston P, Fong WG, Kelly NL, et al (2001). Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol, 3, 128-33. https://doi.org/10.1038/35055027
- Ma B, Wang Y, Zhou X, et al (2014). Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin. J Cancer Res Clin Oncol, 141, 419-29
- Ma TL, Ni PH, Zhong J, et al (2005). Low expression of XIAP-associated factor 1 in human colorectal cancers. Chin J Dig Dis, 6, 10-4. https://doi.org/10.1111/j.1443-9573.2005.00180.x
- Mhawech-Fauceglia P, Yan L, Sharifian M, et al (2014). Stromal expression of fibroblast activation protein alpha (FAP) predicts platinum resistance and shorter recurrence in patients with epithelial ovarian cancer. Cancer Microenviron. [Epub ahead of print]
- Murphy TM, Perry AS, Lawler M (2008). The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. Endocr Relat Cancer, 15, 11-25. https://doi.org/10.1677/ERC-07-0208
- Ng KC, Campos EI, Martinka M, et al (2004). XAF1 expression is significantly reduced in human melanoma. J Invest Dermatol, 123, 1127-34. https://doi.org/10.1111/j.0022-202X.2004.23467.x
- Qi R, Gu J, Zhang Z, et al (2007). Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis. Cancer Gene Ther, 14, 82-90. https://doi.org/10.1038/sj.cgt.7700992
- Qiao L, Gu Q, Dai Y, et al (2008). XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells. Tumour Biol, 29, 122-9. https://doi.org/10.1159/000137831
- Rai B, Bansal A, Patel FD, et al (2014). Radiotherapy for ovarian cancers - redefining the role. Asian Pac J Cancer Prev, 15, 4759-63. https://doi.org/10.7314/APJCP.2014.15.12.4759
- Russell S, Duquette M, Liu J, et al (2014). Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer. FASEB J, 29, 576-88
- Sakemi R, Yano H, Ogasawara S, et al (2007). X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Oncol Rep, 18, 65-70.
- Shibata T, Mahotka C, Wethkamp N, et al (2007). Disturbed expression of the apoptosis regulators XIAP, XAF1, and Smac/DIABLO in gastric adenocarcinomas. Diagn Mol Pathol, 16, 1-8. https://doi.org/10.1097/01.pdm.0000213471.92925.51
- Shibata T, Noguchi T, Takeno S, et al (2008). Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas. Ann Surg Oncol, 15, 3579-87. https://doi.org/10.1245/s10434-008-0062-4
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Wang J, Peng Y, Sun YW, et al (2006). All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology, 130, 747-58. https://doi.org/10.1053/j.gastro.2005.12.017
- Wang Y, Mao H, Hao Q, et al (2012). Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer. Regul Pept, 178, 36-42. https://doi.org/10.1016/j.regpep.2012.06.005
- Wu LM, Zhang F, Zhou L, et al (2010). Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation. BMC Cancer, 10, 399. https://doi.org/10.1186/1471-2407-10-399
- Yang WT, Chen DL, Zhang FQ, et al (2014). Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation. Asian Pac J Cancer Prev, 15, 7825-9. https://doi.org/10.7314/APJCP.2014.15.18.7825
- Yin DT, Chen G, Li HQ, et al (2012). Relationship between methylation status of promoter and expression of XAF1 gene in papillary thyroid carcinoma. Zhonghua Yi Xue Za Zhi, 92, 1967-70.
- Zhang F, Wu LM, Zhou L, et al (2008). Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Ann Surg Oncol, 15, 3494-502. https://doi.org/10.1245/s10434-008-0146-1
- Zhu L, Cheng X, Ding Y, et al (2014a). Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway. Cancer Lett, 343, 80-9. https://doi.org/10.1016/j.canlet.2013.09.017
- Zhu LM, Shi DM, Dai Q, et al (2014b). Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. Oncotarget, 5, 5403-15. https://doi.org/10.18632/oncotarget.2114
Cited by
- Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin’s lymphoma cells vol.37, pp.6, 2016, https://doi.org/10.1007/s13277-015-4705-3
- Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy vol.37, pp.9, 2016, https://doi.org/10.1007/s13277-016-5029-7
- Lentivirus-mediated downregulation of MAT2B inhibits cell proliferation and induces apoptosis in melanoma vol.49, pp.3, 2016, https://doi.org/10.3892/ijo.2016.3603
- Novel recombinant protein FlaA N/C increases tumor radiosensitivity via NF-κB signaling in murine breast cancer cells vol.12, pp.4, 2016, https://doi.org/10.3892/ol.2016.4957
- Marsdeniae tenacissima extract-induced growth inhibition and apoptosis in hepatoma carcinoma cells is mediated through the p53/nuclear factor-κB signaling pathway vol.14, pp.3, 2017, https://doi.org/10.3892/etm.2017.4833